Precision Infectious DiseaseConfirmed
Doctors Paired an Investigational Antibiotic With Phage Therapy in a Near-Untreatable Infection
UC Irvine says a young leukemia patient became the first U.S. patient to receive investigational cefepime-zidebactam, paired with phage therapy, after a multidrug-resistant infection.
Why now
A patient-level case turns antimicrobial resistance, compassionate use, and phage therapy into a concrete life-saving story.
- Overclaim risk
- high
- Primary source
- Official
- Published
- Jul 5, 2026